Empire Asset Assigns Penny Stock Lipocine $21 Price Target, Buy Rating
February 27, 2018 at 11:45 AM EST
Lipocine Inc (NASDAQ: LPCN) is still down 57 percent since the U.S. Food and Drug Administration’s Bone, Reproductive and Urologic ...
